查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701275

美国远端医疗监测市场规模、份额、趋势分析报告（按部署模式、监测类型、最终用途、细分市场预测，2025 年至 2030 年）

U.S. Remote Therapeutic Monitoring Market Size, Share & Trends Analysis Report By Deployment Mode (Cloud & Web-based, On-premise), By Monitoring Type (Therapeutic Data, Non-Physiological Data), By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国远端医疗监测市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，美国远端医疗监测市场预计到2030年将达到9.6981亿美元，2025年至2030年期间的复合年增长率为17.2%。

日益关注资料分析和加强患者照护、有利的政府政策以及可穿戴和行动医疗设备的技术进步是推动市场成长的一些因素。

糖尿病、高血压、心臟病和慢性呼吸系统疾病等慢性疾病负担的增加是远端医疗监测市场最重要的驱动因素之一。管理这些疾病通常需要持续监测，而远端医疗监测 (RTM) 可以即时追踪关键健康指标。 RTM 提供远端监控患者生命征象和治疗进展的解决方案，使慢性疾病的管理变得更加容易，减少就诊次数并改善患者的治疗效果。随着患有慢性疾病的人口不断增长，对管理这些疾病的远端监控技术的需求也在增长。

此外，政府和健康保险公司也越来越认识到远端监控技术在改善医疗保健方面的重要性。例如，医疗保险和医疗补助服务中心（CMS）扩大了远端医疗监控服务的报销政策，将慢性疾病患者的设备使用和护理协调纳入其中。

此外，从按服务收费模式转向基于价值的护理的转变是影响远端医疗监控 (RTM) 市场的一个主要因素。在基于价值的照护模式中，医疗保健提供者受到激励，在尽量降低成本的同时提供优质照护。 RTM 透过使医疗保健提供者能够远端监控患者健康状况、减少医院再入院率和预防併发症来支持基于价值的护理，从而促进市场成长。例如，2025 年 1 月，Smart Pillbox 推出了 HealthBuddy 应用程序，以提高患者的用药依从性。该应用程式透过向用户提供药物提醒和追踪功能来支援治疗监测。

美国远端医疗监测市场报告重点

  • 根据部署模式，云端基础市场在 2024 年占据了最大的市场占有率，预计在 2025 年至 2030 年期间将以最快的复合年增长率成长。这种成长归因于可访问性的提高、即时资料能力、可扩展性、成本效益、提供者之间协作的改善以及强大的安全功能。
  • 根据监测类型，治疗领域占据了市场主导地位，占据了 2024 年最大的收入份额。这是因为它能够提高病人参与和依从性，实现即时监测和调整，并支援资料主导的决策流程。此外，治疗资料有助于优化资源利用率，提高成本效益，符合旨在改善整体健康结果同时有效管理成本的基于价值的护理计划。
  • 根据最终用途，医疗保健提供者部门预计将在 2024 年占据最大的市场占有率。医疗保健提供者是远距患者照护、改善患者沟通、做出资料主导的决策、实现成本效益、受益于监管支持、确保护理的扩充性和可及性、有效地与现有系统集成以及专注于远端医疗预防保健策略方面发挥着关键作用。
  • 根据最终用途，预计患者/看护者部分在预测期内将以最快的复合年增长率成长。
  • 2024 年 12 月，ElectronRx 宣布推出其 purpleDx 智慧型手机应用程序，旨在远端监测肺部疾病患者的肺功能。该应用程式允许用户追踪他们的呼吸健康状况并向医疗保健提供者提供即时资料。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国远端医疗监测 (RTM) 市场变数、趋势与范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 市场机会分析
  • 市场问题分析
  • 美国远端医疗监控（RTM）市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
  • 案例研究
  • EHR 整合 RTM 解决方案
  • 法律规范

第四章美国远端医疗监测 (RTM) 市场：部署模式评估与趋势分析

  • 细分仪表板
  • 美国远端医疗监测（RTM）市场、部署模式变化分析
  • 2018 年至 2030 年美国远端医疗监测 (RTM) 市场规模及趋势分析（依部署模式）
  • 基于云端和 Web
  • 本地

第五章美国远端医疗监测（RTM）市场：监测类型的估计和趋势分析

  • 细分仪表板
  • 美国远端医疗监测（RTM）市场、监测类型变化分析
  • 2018 年至 2030 年美国远端医疗监测 (RTM) 市场规模及趋势分析（依监测类型）
  • 治疗资料
    • 药物依从性
    • 对药物的反应
  • 非生理资料

第六章美国远端医疗监测 (RTM) 市场：最终用途估计与趋势分析

  • 细分仪表板
  • 美国远端医疗监测 (RTM) 市场、最终用途差异分析
  • 2018 年至 2030 年美国远端医疗监测 (RTM) 市场规模及趋势分析（依最终用途）
  • 医疗保健提供者
    • 医院
    • 专科诊所
    • 復健中心
    • 疗养院和长期照护机构
  • 家庭医疗保健
  • 患者和看护者
  • 付款人

第七章竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/列表
    • Zimmer Biomet
    • Medsien, Inc.
    • Adhere+Corporation
    • Academy Medtech Ventures
    • CircleLink Health Inc.
    • Limber Health, Inc.
    • HealthArc
    • Hero Health, Inc.
    • IncludeHealth Inc
    • Propeller Health（Resmed）
Product Code: GVR-4-68040-537-2

U.S. Remote Therapeutic Monitoring Market Growth & Trends:

The U.S. remote therapeutic monitoring market is anticipated to reach USD 969.81 million by 2030 and is anticipated to grow at a CAGR of 17.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing focus on enhanced data analytics and patient care, favorable government policies, and technological advancements in wearables and mobile health devices are some of the factors contributing to market growth.

The increasing burden of chronic diseases such as diabetes, hypertension, heart disease, and chronic respiratory conditions is one of the most significant driver of the remote therapeutic monitoring market. Managing these conditions often requires continuous monitoring, and remote therapeutic monitoring (RTM) allows for real-time tracking of key health metrics. RTM provides a solution to remotely monitor patients' vital signs and therapeutic progress, making it easier to manage chronic conditions, reduce hospital visits, and improve patient outcomes. As the population with chronic diseases continues to grow, the demand for remote monitoring technologies to manage these conditions is also increasing.

Furthermore, governments and health insurers are increasingly acknowledging the significance of remote monitoring technologies in improving healthcare delivery. For instance, the Centers for Medicare & Medicaid Services (CMS) have broadened reimbursement policies for remote therapeutic monitoring services, encompassing device utilization and care coordination for patients with chronic conditions.

Moreover, the transition from fee-for-service models to value-based care is a major factor influencing the remote therapeutic monitoring (RTM) market. In value-based care models, healthcare providers are encouraged to deliver high-quality care while minimizing costs. RTM supports value-based care by allowing healthcare providers to monitor patient health remotely, reduce hospital readmissions, and prevent complications, thereby contributing to market growth. For instance, in January 2025, Smart Pillbox launched the HealthBuddy app to enhance medication adherence for patients. This app supports therapeutic monitoring by providing users with medication reminders and tracking features.

U.S. Remote Therapeutic Monitoring Market Report Highlights:

  • Based on deployment mode, the web & cloud-based segment held the largest market share in 2024 and is expected to register growth at the fastest CAGR from 2025 to 2030. This growth can be attributed to its enhanced accessibility, real-time data capabilities, scalability, cost-effectiveness, improved collaboration among providers, and strong security features.
  • Based on monitoring type, therapeutic segment dominated the market and accounted for the largest revenue share in 2024, owing its ability to improve patient engagement and adherence, enable real-time monitoring and adjustments, and support data-driven decision-making processes. In addition, therapeutic data helps optimize resource utilization for cost-effectiveness and aligns with value-based care initiatives, which aim to improve overall health outcomes while managing costs efficiently.
  • Based on end use, the healthcare providers segment held the largest market share in 2024. Healthcare providers serve as significant end users in the remote therapeutic monitoring market due to their critical role in enhancing patient care through continuous monitoring, improving communication with patients, making data-driven decisions, achieving cost efficiencies, benefiting from regulatory support, ensuring scalability and accessibility of care, integrating with existing systems effectively, and focusing on preventive care strategies.
  • Based on end use, the patients & caregivers segment is expected to register growth at the fastest CAGR during the forecast period.
  • In December 2024, ElectronRx anounced to launch the purpleDx smartphone app, designed for remote monitoring of lung function in patients with pulmonary diseases. The app enables users to track their respiratory health, providing real-time data to healthcare providers.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Deployment Mode
    • 1.2.2. Monitoring Type Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Remote Therapeutic Monitoring (RTM) Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in Wearables and Mobile Health Devices
      • 3.2.1.2. Integration of Artificial Intelligence (AI) and Machine Learning (ML)
      • 3.2.1.3. Growing preference for telemedicine and telehealth solutions
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Data Security and privacy concerns
      • 3.2.2.2. High initial implementation costs
  • 3.3. Market Opportunity Analysis
  • 3.4. Market Challenges Analysis
  • 3.5. U.S. Remote Therapeutic Monitoring (RTM) Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
      • 3.5.2.4. Environmental Landscape
      • 3.5.2.5. Legal Landscape
      • 3.5.2.6. Social Landscape
  • 3.6. Case Study
  • 3.7. EHR Integrated RTM Solution
  • 3.8. Regulatory Framework

Chapter 4. U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment Mode Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Remote Therapeutic Monitoring (RTM) Market Deployment Mode Movement Analysis
  • 4.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by Deployment Mode, 2018 to 2030 (USD Million)
  • 4.4. Cloud & Web-based
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. On-premise
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Remote Therapeutic Monitoring Market Monitoring Type Movement Analysis
  • 5.3. U.S. Remote Therapeutic Monitoring Market Size & Trend Analysis, by Monitoring Type, 2018 to 2030 (USD Million)
  • 5.4. Therapeutic Data
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Therapy Medication Adherence
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Therapy Medication Response
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Non-Physiological Data
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Remote Therapeutic Monitoring (RTM) Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Remote Therapeutic Monitoring (RTM) Market End Use Movement Analysis
  • 6.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Healthcare Providers
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Hospitals
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Specialty Clinics
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Rehabilitation Centers
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Nursing Homes & Long-Term Care Facilities
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Home Healthcare
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Patients & Caregivers
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Payers
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Zimmer Biomet
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Medsien, Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Adhere+ Corporation
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Academy Medtech Ventures
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. CircleLink Health Inc.
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Limber Health, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. HealthArc
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Hero Health, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. IncludeHealth Inc
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Propeller Health (Resmed)
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of secondary sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. Remote Therapeutic Monitoring (RTM) Market: Market outlook
  • Fig. 5 U.S. Remote Therapeutic Monitoring (RTM) Market: Segment outlook
  • Fig. 6 U.S. Remote Therapeutic Monitoring (RTM) Market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. Remote Therapeutic Monitoring (RTM) Market driver impact
  • Fig. 9 U.S. Remote Therapeutic Monitoring (RTM) Market restraint impact
  • Fig. 10 U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment mode outlook and key takeaways
  • Fig. 11 U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment mode movement analysis
  • Fig. 12 Cloud & Web-based market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 13 On-premise market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type outlook and key takeaways
  • Fig. 15 U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type movement analysis
  • Fig. 16 Therapeutic data market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Non-physiological data market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Remote Therapeutic Monitoring (RTM) Market: End Use outlook and key takeaways
  • Fig. 19 U.S. Remote Therapeutic Monitoring (RTM) Market: End Use movement analysis
  • Fig. 20 Healthcare providers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Home healthcare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Patients & caregivers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Payers market estimates and forecast, 2018 - 2030 (USD Million)